Life Technologies Chooses Rhenium to Distribute Products in Israel
December 8, 2011
GLASGOW, Scotland, Life Technologies Corporation today announced that it has chosen Rhenium as the principal distributor of its product portfolio for the Israeli market. The deal represents Life's continued growth in the region. "We want our customers to be able to access the broad Research and Development portfolio of Life Technologies' products and services including, [...]
December 8, 2011
NEW YORK, IBM today announced it is contributing a massive database of chemical data extracted from millions of patents and scientific literature to the National Institutes of Health. This contribution will allow researchers to more easily visualize important relationships among chemical compounds to aid in drug discovery and support advanced cancer research. In collaboration with [...]
December 8, 2011
BERLIN and BURLINGTON, Mass., caprotec bioanalytics GmbH announced today the discovery of previously unknown specific drug-protein interactions for several anti-cancer drugs and the identification of potential novel co-targets of the drug molecules through the use of company's CCMS technology. These scientific findings are published in peer-reviewed articles in Journal of Proteomics, Proteomics and Journal of [...]
NCSED Chooses Instem’s Integrated Software Suite for Preclinical Studies in China
December 8, 2011
CONSHOHOCKEN, Pa., Instem, a leading provider of early development software applications, announced today that China’s National Center for Safety Evaluation of Drugs (NCSED) has selected Instem’s Provantis® software solution suite to automate their preclinical study processes. The NCSED, a subsidiary of the Chinese State Food & Drug Administration (SFDA), manages and sponsors government and commercial [...]
Cellectis bioresearch and Syngene announce partnership on the development of customized cell lines
December 8, 2011
Paris (France) et Bangalore (India), Cellectis bioresearch, the specialist in genome customization and commercial subsidiary of Cellectis (Alternext: ALCLS), and Syngene International Ltd, an internationally reputed contract research and manufacturing services (CRAMS) organization and subsidiary of BIOCON Ltd, India’s largest biotechnology company by revenue, announced today that they have entered into an agreement to develop [...]
December 8, 2011
SEATTLE & SAN ANTONIO, Texas, NanoString Technologies, Inc., a privately held provider of life science tools for translational research and developer of molecular diagnostics, today announced positive results from the first clinical validation study of its first in vitro diagnostic product, a breast cancer assay based on the PAM50 gene expression signature. The study, which [...]
New Fully Automated Sample Prep Solution from Omni International
December 8, 2011
Replace your homogenizer, liquid handler, pipette & weighing platform, all in one automated machine! Kennesaw, GA (PRWEB) December 08, 2011 The Omni LH96 combines multiple sample prep steps into one versatile, efficient and automated device. Quite literally, what used to take hours can now be completed in a matter of minutes. The LH96 delivers significantly [...]
Genome Sequencing Reveals Previously Unreported Genetic Changes in Triple Negative Breast Tumors
December 8, 2011
DALLAS, PHOENIX, and THE WOODLANDS, Texas, Initial results from an ongoing clinical trial, the first designed to examine the utility of whole-genome sequencing for triple negative breast cancer, were reported today during the CRTC-AACR San Antonio Breast Cancer Symposium. The results indicate activation of targets not previously associated with triple negative disease and could point [...]
December 8, 2011
SELANGOR, Malaysia, Agilent Technologies Inc. (NYSE: A) and Monash University Sunway campus today announced a collaboration to promote talent and skills development for genomics research in Malaysia. This partnership, the first of its kind for Agilent with a university in Malaysia, will help Malaysia assert itself as a leading center for life sciences research and [...]
Phenomenex Founder & CEO, Fasha Mahjoor Invited to Buckingham Palace
December 8, 2011
TORRANCE, Calif., Fasha Mahjoor, managing director of Phenomenex Ltd, UK and founder and CEO of Phenomenex, a global leader in the separation sciences, has been invited to dinner at Buckingham Palace next month for the 90th birthday celebration of His Royal Highness, Prince Philip, The Duke of Edinburgh, in support of The Duke of Edinburgh [...]